Connect With Us
Our team is ready to connect with you and learn more about your science.
Corporate Business Development
Search & Evaluation
| ||
|---|---|---|
|
Diabetes, Obesity, and Complications
| ||
|
Digital Health
|
Jim Koers (Clinical Capabilities)
| |
|
Genetic Medicines
|
Amanda Placone, PhD (Gene Therapy and Editing)
| |
|
Immunology
| ||
|
Molecule Innovation (Biologics)
| ||
|
Molecule Innovation (Discovery Chemistry)
|
Jim Koers (Novel Drug Development Methods)
| |
|
Neuroscience
|
Jenny Laird, PhD (Neurology and Pain)
|
Hallee Foster (Psychiatry)
|
|
Oncology
| ||
Adrienne Brown
Group VP, Head of Corporate Business Development
Transactions
| |
|---|---|
|
Head of Corporate Business Development Transactions and M&A
|
Jake Shuman
|
|
Diabetes, Obesity, and Complications
|
Tim Dolan
|
|
Genetic Medicines
|
Michael Johnson
|
|
Immunology
|
Vacant
|
|
International and Manufacturing
|
James A. (Andy) McGee
|
|
Neuroscience
|
Jeremy Fitch
|
|
Oncology
|
David Kutoloski
|
Alliance & Innovation Management
| |
|---|---|
|
Head of Alliance and Innovation Management
|
Wanda Rutledge-Gordon, PhD
|
|
Acquisitions
|
Kristi Huntington
|
|
Diabetes, Obesity, and Complications
|
Jamie McKenzie
|
|
Genetic Medicines, Neuroscience, Discovery/Chemistry/Research/Technology
|
Linda Kehn
|
|
Immunology, Oncology
|
Brent Harvey
|
|
International, Biotherapeutic Discovery Research
|
Lisa Keough
|
Lilly Catalyze360
Nisha Nanda, PhD
Group VP, Head of Lilly Catalyze360
Lilly Ventures
| |
|---|---|
|
Lilly Ventures Global Head
|
Brad Robling
|
|
Lilly Venture Science Global Head
|
Jim MacKrell, PhD
|
|
Lilly Venture Science Europe Hub
|
Laura Lane, PhD
|
|
Lilly Venture Science West Coast Hub
|
Tim Luker, PhD
|
|
Lilly Venture Science Asia Hub
|
Gurkee Singh, PhD
|
Lilly Gateway Labs
| |
|---|---|
|
Contact Us
| |
|
Lilly Gateway Labs Global Head
|
Julie Gilmore, PhD
|
|
Lilly Gateway Labs Boston Hub
|
Vanessa Barth, PhD
|
|
Lilly Gateway Labs San Francisco Hub
|
Nina Kosaric, PhD
|
|
Lilly Gateway Labs San Diego Hub
|
Kathleen Lin, PhD
|
|
Lilly Gateway Labs Asia Hub
|
Shea McMurtry, PhD
|
Lilly ExploR&D
|
Contact
|
|---|---|
|
Lilly ExploR&D Head
|
Contact:
Tom Hopkins, MD, PhD
|
|
Lilly ExploR&D CMO
|
Contact:
Tom Hopkins, MD, PhD
|
|
Lilly ExploR&D Head of Clinical Program Management
|
Contact:
Daniel Mudra, PhD
|
|
Lilly ExploR&D External Partnering
|
Contact:
Everett Perkins
|
Lilly Catalyze360 Portfolio Management
| |
|---|---|
|
Lilly Catalyze360 Portfolio Management
|
Julie Gilmore, PhD
|
|
Lilly Catalyze360 Program Management
|
Lance Pfeifer, PhD
|
|
Lilly Catalyze360 Innovation
|
Tom Marron, PhD
|
|
Lilly Catalyze360 Artificial Intelligence/Machine Learning
|
Aliza Apple, PhD
|
Corporate Business Development
We seek the most powerful science for strategic partnerships, licensing and potential acquisitions in our core therapeutic areas. Through Search & Evaluation, Transactions and Alliance & Innovation Management, we operate on the frontiers of medicine development.
Lilly Catalyze360
Built to engage biotechs at the earliest stages and agnostic of therapeutic area, we offer a global investment arm with Lilly Ventures; lab facilities and scientific engagement through Lilly Gateway Labs; and R&D solutions via Lilly ExploR&D.